Eidogen-Sertanty Releases iKinase iPhone Application

San Diego, CA (January 2, 2010) – Eidogen-Sertanty, Inc., a San Diego-based computational drug discovery solutions provider, announced today the release of iKinase, the world's first iPhone/iPod-Touch application facilitating kinome structure activity information browsing.

iKinase provides access to top-kinase-active molecules and corresponding structure activity information from Eidogen-Sertanty's Kinase Knowledgebase (KKB). With iKinase, a user can search for Kinase targets by standardized names, identify top-active molecules for each target, and drill-down into more detail.

For more information, including screenshots, video demonstration, and download details, please see the iKinase - iPhone and iPod Touch Application information page.

For more information, please contact:

Steve Muskal
760-651-2885
pr@eidogen-sertanty.com

About Eidogen-Sertanty, Inc.
Eidogen-Sertanty, formed in March 2005 from the merger of Eidogen and Sertanty, is a privately held company providing pioneering knowledge-driven discovery solutions to biotechnology and pharmaceutical organizations.  Eidogen-Sertanty’s unique and powerful suite of software, databases, and drug discovery services enable customers and collaborators to apply a knowledge-driven discovery approach to a variety of workflows and processes, including target selection and prioritization, library building and compound prioritization, and lead design and optimization.  To find out more about Eidogen-Sertanty and their products and services please visit www.eidogen-sertanty.com.